These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1318878)

  • 1. In-vitro activity of sparfloxacin, pefloxacin, ciprofloxacin and temafloxacin against clinical isolates of Acinetobacter spp.
    Joly-Guillou ML; Bergogne-Bérézin E
    J Antimicrob Chemother; 1992 Apr; 29(4):466-8. PubMed ID: 1318878
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterisation of DNA gyrase and measurement of drug accumulation in clinical isolates of Acinetobacter baumannii resistant to fluoroquinolones.
    Moreau NJ; Houot S; Joly-Guillou ML; Bergogne-Bérézin E
    J Antimicrob Chemother; 1996 Dec; 38(6):1079-83. PubMed ID: 9023657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
    Gorzynski EA; Gutman SI; Allen W
    Antimicrob Agents Chemother; 1989 Apr; 33(4):591-2. PubMed ID: 2524998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compared antibacterial activity of a new fluoroquinolone, sparfloxacin (AT 4140, RP 64206) and four other fluoroquinolones against 332 strains of enteropathogen bacteria].
    Le Noc P; Croizé J; Le Noc D
    Pathol Biol (Paris); 1993 Apr; 41(4):294-301. PubMed ID: 8233625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
    Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
    Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
    Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice.
    Gelber RH; Iranmanesh A; Murray L; Siu P; Tsang M
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2544-7. PubMed ID: 1336951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bactericidal activity of ciprofloxacin and sparfloxacin. Comparison with others active antibiotics against Pasteurella multocida].
    Gastine C; Donnio PY; Travert MF; Avril JL
    Presse Med; 1995 Mar; 24(11):519-22. PubMed ID: 7770389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
    Malmborg AS; Ahlén S
    Chemotherapy; 1993; 39(1):32-5. PubMed ID: 8383030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bactericidal activity of quinolones (including sparfloxacin) against Enterococcus; in vitro antagonisms with gentamicin].
    Watine J; Charet JC
    Pathol Biol (Paris); 1997 May; 45(5):430-2. PubMed ID: 9296098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
    Wallrauch C; Voss A; Milatovic D; Braveny I
    Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine.
    Mahr G; Sörgel F; Granneman GR; Kinzig M; Muth P; Patterson K; Fuhr U; Nickel P; Stephan U
    Clin Pharmacokinet; 1992; 22 Suppl 1():90-7. PubMed ID: 1319876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures.
    Förster C; Rücker M; Shakibaei M; Baumann-Wilschke I; Vormann J; Stahlmann R
    Arch Toxicol; 1998 Jun; 72(7):411-9. PubMed ID: 9708880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro bactericidal effect of temafloxacin and tosufloxacin against streptococci].
    Aubert G; Pozzetto B; Dorche G
    Pathol Biol (Paris); 1991 Dec; 39(10):1002-5. PubMed ID: 1666667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of ciprofloxacin, temafloxacin, azithromycin, clarithromycin and metronidazole against Giardia lamblia.
    Ikerd TR; Koletar SL
    J Antimicrob Chemother; 1993 Apr; 31(4):615-7. PubMed ID: 8390436
    [No Abstract]   [Full Text] [Related]  

  • 16. Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae.
    Dalhoff A
    Drugs; 1995; 49 Suppl 2():194-6. PubMed ID: 8549301
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
    Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB; Swanson RN
    Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.
    Morrissey I; Smith JT
    J Antimicrob Chemother; 1992 May; 29(5):589-90. PubMed ID: 1320605
    [No Abstract]   [Full Text] [Related]  

  • 20. Killing kinetics of four quinolones against gram-positive cocci.
    Cantón E; Ramon MS; Jimenez MT; Martinez JP
    Chemotherapy; 1993; 39(6):394-9. PubMed ID: 8222866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.